Overview
- 66 inspections across 63 sites are on record.
- 160 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2023-02-02.
At a glance
Inspections
66
Sites
63
Observations
160
Career since
Feb 2015
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Genentech, Inc. | 2 Feb 2023 | Human Drugs | On file |
| Florida Cirtech Inc | 8 Jun 2021 | Human Drugs | On file |
| Valescent Pharmaceuticals, Inc. dba VPI Compounding | 3 Mar 2021 | Human Drugs | |
| Fresenius USA Manufacturing, Inc. | 13 Aug 2020 | Human Drugs | On file |
| Front Range Laboratories, Inc. | 20 Mar 2020 | Human Drugs | On file |
Sites inspected
Genentech, Inc.South San Francisco, United States1 insp.
Florida Cirtech IncGreeley, United States1 insp.
Valescent Pharmaceuticals, Inc. dba VPI CompoundingCentennial, United States1 insp.
Fresenius USA Manufacturing, Inc.Ogden, United States1 insp.
Front Range Laboratories, Inc.Loveland, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Zachary A Bogorad4 shared
Zachary L Stamm3 shared
Jamie L Dion3 shared
Dustin M James2 shared
Jennifer M Gogley2 shared
Uttaniti Limchumroon2 shared
Zachery L Miller2 shared
Gerard T Schneider2 shared
Christopher M Jenner2 shared
Laura B Kennedy2 shared
Full investigator report
Get the verbatim findings behind Nayan J Patel's 160 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site